For early stage HCC (BCLC: 0, A; TNM: IA, IB; Chinese: Ia, Ib) detection, our model demonstrated significantly improved performance with 5–20% increases of AUC compared with AFP (cutoff 400 ng/mL). The gene discussed is AFP; the disease is hepatocellular carcinoma.